Vestcor Inc Has $4.17 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vestcor Inc decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 12.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 8,478 shares of the medical equipment provider's stock after selling 1,200 shares during the period. Vestcor Inc's holdings in Intuitive Surgical were worth $4,165,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in the business. M&G Plc increased its holdings in shares of Intuitive Surgical by 53.5% in the second quarter. M&G Plc now owns 5,069 shares of the medical equipment provider's stock valued at $2,256,000 after buying an additional 1,766 shares in the last quarter. NorthCrest Asset Manangement LLC boosted its position in shares of Intuitive Surgical by 3.4% in the 2nd quarter. NorthCrest Asset Manangement LLC now owns 1,410 shares of the medical equipment provider's stock valued at $627,000 after purchasing an additional 46 shares during the period. Great Valley Advisor Group Inc. boosted its position in shares of Intuitive Surgical by 8.3% in the 2nd quarter. Great Valley Advisor Group Inc. now owns 2,477 shares of the medical equipment provider's stock valued at $1,102,000 after purchasing an additional 189 shares during the period. ORG Partners LLC increased its stake in Intuitive Surgical by 3,411.1% in the 2nd quarter. ORG Partners LLC now owns 316 shares of the medical equipment provider's stock worth $138,000 after purchasing an additional 307 shares in the last quarter. Finally, Country Club Bank raised its holdings in Intuitive Surgical by 2.0% during the 2nd quarter. Country Club Bank now owns 3,031 shares of the medical equipment provider's stock worth $1,349,000 after buying an additional 60 shares during the period. Institutional investors own 83.64% of the company's stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. Piper Sandler reiterated an "overweight" rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Finally, Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $550.28.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $5.51 during trading hours on Wednesday, reaching $543.60. The company's stock had a trading volume of 999,391 shares, compared to its average volume of 1,442,025. The company has a market cap of $193.62 billion, a price-to-earnings ratio of 87.40, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a one year low of $314.38 and a one year high of $556.23. The business's 50-day moving average is $518.23 and its 200-day moving average is $476.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the sale, the director now owns 821 shares in the company, valued at $402,519.88. This represents a 35.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Mark Brosius sold 2,115 shares of the firm's stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the sale, the insider now directly owns 295 shares in the company, valued at $145,113.45. This trade represents a 87.76 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,755 shares of company stock worth $26,273,943 over the last 90 days. Insiders own 0.90% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.